Biotechnology future.

What does the future hold for the Biotechnology industry as many of the small companies shift gears from research to Commercialization and in-licensing. I work for a small biotech or biopharmaceutical company as they are reffering to themselves now and I have some concerns. At this point we have licensed a very good novel antibiotic that I believe will do very well in the market place as our first commercial venture. My concerns arise as more and more small companies license out molecules to market instead of creating new ones like they did in the past. There is not an endless supply of unmarketed drugs out there for companies to choose from and as more companies inlicense products the well will keep drying up. Even now I feel that many of the licensed products are me-too and second class agents that merely compete on price and not clear clinical advantages.
Acute therapies will be hit the hardest because this is where the biotechs did there best work since the major pharma companies are all going the chronic care direction. It will be the patient that is ultimately hurt by this.
Another concern I have deals with the markets view of all of this. Will investors flee from biotech if there are no new good ideas and any radical ideas for new compounds? Why invest in a small pharmaceutical company selling a copy of a major pharma brand when you could invest in the real deal and have greater security? People don't invest money in the same old,same old they look for companies and people who have original ideas who are way ahead of their time that is what investing is about, so why would anyone be excited about an in-licensing minor biotech company that has gotten out of research and development?
Scary prospect for someone who relies on having new and novel products to sell.